Short-course chemotherapy for tuberculosis with mainly twice-weekly isoniazid and rifampin. Community physicians' seven-year experience with mainly outpatients.
about
Tuberculous pleural effusion: 6-month therapy with isoniazid and rifampin.Does directly observed therapy (DOT) reduce drug resistant tuberculosis?Adverse reactions to first-line antituberculosis drugs.Long term efficacy of DOTS regimens for tuberculosis: systematic review.Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study.Tuberculous pleural effusion: experience with six months of treatment with isoniazid and rifampicin.Antituberculosis treatment-induced hepatotoxicity: role of predictive factors.The value of effective public tuberculosis treatment: an analysis of opportunity costs associated with multidrug resistant tuberculosis in Latvia.Evolving concepts of the epidemiology, diagnosis, and therapy of Mycobacterium tuberculosis infection.Risk Factors of Hepatotoxicity During Anti-tuberculosis Treatment.Incidence of hepatotoxicity due to antitubercular medicines and assessment of risk factors.Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment.N-acetyltransferase 2, cytochrome P4502E1 and glutathione S-transferase genotypes in antitubercular treatment-induced hepatotoxicity in North Indians.Role of polymorphic N-acetyl transferase2 and cytochrome P4502E1 gene in antituberculosis treatment-induced hepatitis.
P2860
Q33366804-2317E7AE-F5F9-4132-9C28-AAE69EEE5B28Q33788435-22C0B4A4-98D8-4398-A7D0-A8C00C32B68FQ34497890-14E4D22C-EEA6-48A3-8931-5C4AC99BA4F3Q36482540-567C4CB7-DF8B-4217-874E-6EBC5121A9ACQ36512029-AB4ADD7E-B774-4C9C-A11E-D2832EB4D1DBQ36577820-41FFE390-ECA2-47C5-A215-108AF425AD25Q36680092-592B5CD9-7AD5-44C4-B9D7-E37057D5CD4FQ36797843-138DBF3C-38BA-4074-8CB8-6D75142CAFBDQ36988188-8B2740E7-F3B4-4C2C-8E0E-994BA86CAD08Q37043444-511F3291-A9E2-4CF3-BF0F-B0E9E4244CDBQ39683838-9CD1EE8D-9595-410D-A434-45749708F0B2Q44164447-E57D2151-4FED-4C51-84C6-5BD5FCA4B2D8Q45766101-BC8DFEBD-9402-4714-AFD0-BE0DD024B766Q54391325-C2E1E59F-12BB-4228-B2D5-82EE528AF2F9
P2860
Short-course chemotherapy for tuberculosis with mainly twice-weekly isoniazid and rifampin. Community physicians' seven-year experience with mainly outpatients.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
1984年學術文章
@zh
1984年學術文章
@zh-hant
name
Short-course chemotherapy for ...... ience with mainly outpatients.
@en
Short-course chemotherapy for ...... ience with mainly outpatients.
@nl
type
label
Short-course chemotherapy for ...... ience with mainly outpatients.
@en
Short-course chemotherapy for ...... ience with mainly outpatients.
@nl
prefLabel
Short-course chemotherapy for ...... ience with mainly outpatients.
@en
Short-course chemotherapy for ...... ience with mainly outpatients.
@nl
P2093
P1476
Short-course chemotherapy for ...... ience with mainly outpatients.
@en
P2093
P304
P356
10.1016/0002-9343(84)90697-1
P407
P577
1984-08-01T00:00:00Z